Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
44
AFG Quote, Financials, Valuation and Earnings
Last price:
$125.54
Seasonality move
:
5.72%
Day range:
$124.55 - $126.66
52-week range:
$118.97 - $150.19
Dividend yield:
2.39%
P/E ratio:
11.97x
P/S ratio:
1.28x
P/B ratio:
2.38x
Volume:
521.8K
Avg. volume:
610.4K
1-year change:
-4.48%
Market cap:
$10.6B
Revenue:
$8.3B
EPS (TTM):
$10.57
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $6.2B | $6.8B | $7.7B | $8.3B | |
| Revenue Growth (YoY) | -7.29% | 9.89% | 8.7% | 14.1% | 7.12% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $80M | $113M | $117M | $146M | $124M | |
| Operating Expenses | $279M | $264M | $255M | $305M | $319M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $88M | $94M | $85M | $76M | $76M | |
| EBT. Incl. Unusual Items | $339M | $1.3B | $1.1B | $1.1B | $1.1B | |
| Earnings of Discontinued Ops. | $407M | $914M | -- | -- | -- | |
| Income Tax Expense | $25M | $254M | $225M | $221M | $237M | |
| Net Income to Company | $721M | $2B | $898M | $852M | $887M | |
| Minority Interest in Earnings | $11M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $732M | $2B | $898M | $852M | $887M | |
| Basic EPS (Cont. Ops) | $8.25 | $23.44 | $10.55 | $10.06 | $10.57 | |
| Diluted EPS (Cont. Ops) | $8.20 | $23.30 | $10.53 | $10.05 | $10.57 | |
| Weighted Average Basic Share | $88.7M | $85.1M | $85.1M | $84.7M | $83.9M | |
| Weighted Average Diluted Share | $89.2M | $85.6M | $85.3M | $84.8M | $83.9M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $427M | $1.4B | $1.2B | $1.1B | $1.2B | |
| Revenue (Reported) | $5.7B | $6.2B | $6.8B | $7.7B | $8.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $427M | $1.4B | $1.2B | $1.1B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.6B | $1.7B | $1.9B | $2.1B | $2.1B | |
| Revenue Growth (YoY) | 17833.33% | 2.79% | 15.01% | 9.33% | 2.97% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $18M | $43M | $24M | $46M | $32M | |
| Operating Expenses | $87M | $68M | $68M | $78M | $78M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $24M | $23M | $20M | $19M | $19M | |
| EBT. Incl. Unusual Items | $344M | $445M | $346M | $335M | $320M | |
| Earnings of Discontinued Ops. | $427M | -- | -- | -- | -- | |
| Income Tax Expense | $77M | $90M | $70M | $72M | $65M | |
| Net Income to Company | $694M | $355M | $276M | $263M | $255M | |
| Minority Interest in Earnings | -$2M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $692M | $355M | $276M | $263M | $255M | |
| Basic EPS (Cont. Ops) | $8.01 | $4.18 | $3.24 | $3.14 | $3.04 | |
| Diluted EPS (Cont. Ops) | $7.93 | $4.18 | $3.24 | $3.13 | $3.03 | |
| Weighted Average Basic Share | $86.6M | $84.8M | $85.1M | $83.8M | $84.2M | |
| Weighted Average Diluted Share | $87.1M | $85M | $85.3M | $83.9M | $84.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $368M | $468M | $366M | $354M | $339M | |
| Revenue (Reported) | $1.6B | $1.7B | $1.9B | $2.1B | $2.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $368M | $468M | $366M | $354M | $339M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $6.2B | $6.8B | $7.7B | $8.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $80M | $113M | $117M | $146M | $124M | |
| Operating Expenses | $279M | $264M | $255M | $305M | $319M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $88M | $94M | $85M | $76M | $76M | |
| EBT. Incl. Unusual Items | $339M | $1.3B | $1.1B | $1.1B | $1.1B | |
| Earnings of Discontinued Ops. | $407M | $914M | -- | -- | -- | |
| Income Tax Expense | $25M | $254M | $225M | $221M | $237M | |
| Net Income to Company | $721M | $2B | $898M | $852M | $887M | |
| Minority Interest in Earnings | $11M | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $732M | $2B | $898M | $852M | $887M | |
| Basic EPS (Cont. Ops) | $8.51 | $23.41 | $10.55 | $10.08 | $10.58 | |
| Diluted EPS (Cont. Ops) | $8.42 | $23.28 | $10.53 | $10.05 | $10.57 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $427M | $1.4B | $1.2B | $1.1B | $1.2B | |
| Revenue (Reported) | $5.7B | $6.2B | $6.8B | $7.7B | $8.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $427M | $1.4B | $1.2B | $1.1B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.2B | $6.8B | $7.7B | $8.3B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $113M | $117M | $146M | $124M | -- | |
| Operating Expenses | $264M | $255M | $305M | $319M | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $94M | $85M | $76M | $76M | -- | |
| EBT. Incl. Unusual Items | $1.3B | $1.1B | $1.1B | $1.1B | -- | |
| Earnings of Discontinued Ops. | $914M | -- | -- | -- | -- | |
| Income Tax Expense | $254M | $225M | $221M | $237M | -- | |
| Net Income to Company | $2B | $898M | $852M | $887M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2B | $898M | $852M | $887M | -- | |
| Basic EPS (Cont. Ops) | $23.41 | $10.55 | $10.08 | $10.58 | -- | |
| Diluted EPS (Cont. Ops) | $23.28 | $10.53 | $10.05 | $10.57 | -- | |
| Weighted Average Basic Share | $340.5M | $340.4M | $338.7M | $335.7M | -- | |
| Weighted Average Diluted Share | $342.4M | $341.2M | $339.2M | $335.8M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $1.2B | $1.1B | $1.2B | -- | |
| Revenue (Reported) | $6.2B | $6.8B | $7.7B | $8.3B | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.4B | $1.2B | $1.1B | $1.2B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.7B | $2.1B | $872M | $1.2B | $1.4B | |
| Short Term Investments | $9.1B | $10.4B | $10.1B | $10.4B | $540M | |
| Accounts Receivable, Net | $4.5B | $4.8B | $5.3B | $5.9B | $6.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $768M | $834M | $917M | $961M | $1B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $16.7B | $19B | $18.1B | $19.7B | $10.8B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $11.2B | $12.9B | $12.8B | $13.3B | $13.5B | |
| Goodwill | $176M | $246M | $246M | $305M | $305M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $73.7B | $28.9B | $28.8B | $29.8B | $30.8B | |
| Accounts Payable | $3.9B | $4.3B | $1B | $1.2B | $1.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.9B | $4.3B | $1B | $1.2B | $1.2B | |
| Long-Term Debt | $2B | $2B | $1.5B | $1.5B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $66.9B | $23.9B | $24.8B | $25.5B | $26.4B | |
| Common Stock | $86M | $85M | $85M | $84M | $84M | |
| Other Common Equity Adj | $1.3B | $119M | -$543M | -$319M | -$240M | |
| Common Equity | $6.8B | $5B | $4.1B | $4.3B | $4.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6.8B | $5B | $4.1B | $4.3B | $4.5B | |
| Total Liabilities and Equity | $73.7B | $28.9B | $28.8B | $29.8B | $30.8B | |
| Cash and Short Terms | $10.7B | $12.5B | $11B | $11.6B | $1.9B | |
| Total Debt | $2B | $2B | $1.5B | $1.5B | $1.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.7B | $2.1B | $872M | $1.2B | $1.4B | |
| Short Term Investments | $9.1B | $10.4B | $10.1B | $10.4B | $540M | |
| Accounts Receivable, Net | $4.5B | $4.8B | $5.3B | $5.9B | $6.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $768M | $834M | $917M | $961M | $1B | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $16.7B | $19B | $18.1B | $19.7B | $10.8B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $11.2B | $12.9B | $12.8B | $13.3B | $13.5B | |
| Goodwill | $176M | $246M | $246M | $305M | $305M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $73.7B | $28.9B | $28.8B | $29.8B | $30.8B | |
| Accounts Payable | $3.9B | $4.3B | $1B | $1.2B | $1.2B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $3.9B | $4.3B | $1B | $1.2B | $1.2B | |
| Long-Term Debt | $2B | $2B | $1.5B | $1.5B | $1.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $66.9B | $23.9B | $24.8B | $25.5B | $26.4B | |
| Common Stock | $86M | $85M | $85M | $84M | $84M | |
| Other Common Equity Adj | $1.3B | $119M | -$543M | -$319M | -$240M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $6.8B | $5B | $4.1B | $4.3B | $4.5B | |
| Total Liabilities and Equity | $73.7B | $28.9B | $28.8B | $29.8B | $30.8B | |
| Cash and Short Terms | $10.7B | $12.5B | $11B | $11.6B | $1.9B | |
| Total Debt | $2B | $2B | $1.5B | $1.5B | $1.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $721M | $2B | $898M | $852M | $887M | |
| Depreciation & Amoritzation | $299M | $187M | $100M | $78M | $81M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$533M | -$350M | -$644M | -$794M | -$769M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.2B | $1.7B | $1.2B | $2B | $1.2B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$706M | $1.4B | -$10M | -$208M | -$9M | |
| Cash From Investing | -$1.6B | -$436M | -$1.1B | $414M | $95M | |
| Dividends Paid (Ex Special Dividend) | -$334M | -$2.4B | -$1.2B | -$684M | -$788M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $634M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$150M | -- | -$477M | -$21M | -- | |
| Repurchase of Common Stock | -$313M | -$319M | -$11M | -$213M | -- | |
| Other Financing Activities | $18M | $670M | $324M | -$1.1B | -$295M | |
| Cash From Financing | -$123M | -$2B | -$1.4B | -$2B | -$1.1B | |
| Beginning Cash (CF) | $2.3B | $2.8B | $2.1B | $872M | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $496M | -$679M | -$1.3B | $353M | $181M | |
| Ending Cash (CF) | $2.8B | $2.1B | $872M | $1.2B | $1.4B | |
| Levered Free Cash Flow | $2.2B | $1.7B | $1.2B | $2B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $694M | $355M | $276M | $263M | $255M | |
| Depreciation & Amoritzation | $51M | $27M | $22M | $18M | $21M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $64M | $637M | $1.2B | $1B | $1.7B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $487M | $289M | $110M | $756M | $674M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$646M | -$229M | $260M | -- | -$9M | |
| Cash From Investing | -$792M | -$333M | $11M | -$45M | -$21M | |
| Dividends Paid (Ex Special Dividend) | -$215M | -$892M | -$224M | -$186M | -$403M | |
| Special Dividend Paid | $2M | $6M | $2M | $1.5M | $4M | |
| Long-Term Debt Issued | -$1M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$41M | -- | -- | |
| Repurchase of Common Stock | -$80M | -$1M | -$1M | -$60M | -- | |
| Other Financing Activities | -$193M | $229M | $219M | -$465M | -$170M | |
| Cash From Financing | -$632M | -$658M | -$43M | -$707M | -$569M | |
| Beginning Cash (CF) | $3.7B | $2.8B | $794M | $1.2B | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$937M | -$702M | $78M | $4M | $84M | |
| Ending Cash (CF) | $2.8B | $2.1B | $872M | $1.2B | $1.4B | |
| Levered Free Cash Flow | $487M | $289M | $110M | $756M | $674M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $721M | $2B | $898M | $852M | $887M | |
| Depreciation & Amoritzation | $299M | $187M | $100M | $78M | $81M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$533M | -$350M | -$644M | -$794M | -$769M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.2B | $1.7B | $1.2B | $2B | $1.2B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$706M | $1.4B | -$10M | -$208M | -$9M | |
| Cash From Investing | -$1.6B | -$436M | -$1.1B | $414M | $95M | |
| Dividends Paid (Ex Special Dividend) | -$334M | -$2.4B | -$1.2B | -$684M | -$788M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$477M | -$21M | -- | |
| Repurchase of Common Stock | -$313M | -$319M | -$11M | -$213M | -- | |
| Other Financing Activities | $18M | $670M | $324M | -$1.1B | -$295M | |
| Cash From Financing | -$123M | -$2B | -$1.4B | -$2B | -$1.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $496M | -$679M | -$1.3B | $353M | $181M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.2B | $1.7B | $1.2B | $2B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2B | $898M | $852M | $887M | -- | |
| Depreciation & Amoritzation | $187M | $100M | $78M | $81M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$350M | -$644M | -$794M | -$769M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.7B | $1.2B | $2B | $1.2B | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | $1.4B | -$10M | -$208M | -$9M | -- | |
| Cash From Investing | -$436M | -$1.1B | $414M | $95M | -- | |
| Dividends Paid (Ex Special Dividend) | -$2.4B | -$1.2B | -$684M | -$788M | -- | |
| Special Dividend Paid | $26M | $12M | $5.5M | $6.5M | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$477M | -$21M | -- | -- | |
| Repurchase of Common Stock | -$319M | -$11M | -$213M | -- | -- | |
| Other Financing Activities | $670M | $324M | -$1.1B | -$295M | -- | |
| Cash From Financing | -$2B | -$1.4B | -$2B | -$1.1B | -- | |
| Beginning Cash (CF) | $11.3B | $5.1B | $3.9B | $4.8B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$679M | -$1.3B | $353M | $181M | -- | |
| Ending Cash (CF) | $10.7B | $3.8B | $4.3B | $4.9B | -- | |
| Levered Free Cash Flow | $1.7B | $1.2B | $2B | $1.2B | -- | |
Get AFG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AFG
Sector
P/E ratio
11.97x
11.41x
PEG ratio
2.31x
0.39x
P/B ratio
2.38x
1.06x
Price / LTM sales
1.28x
2.51x
Growth Metrics
AFG
Sector
Revenue growth
2.97%
7.05%
Earnings growth
-3.2%
6.59%
Revenue (5-year growth)
6.24%
5.27%
Earnings forecast
$3.01
$0.56
Profitability
AFG
Sector
Profitability FY 2024
--
$178.8M
Return on invested capital
15.07%
5.47%
Return on assets
2.9%
0.99%
Return on equity
20.11%
9.4%
Earnings Date
Last Earnings Date
Feb
4
Next Earnings Date
May
1
Estimated Next Earnings Date
May
6
Balance Sheet
AFG
Sector
Total cash
$1.9B
$497.5M
Short term investments
$540M
$281.2M
Total assets
$30.8B
$4.5B
Long term debt
$1.5B
$323M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
